Rachh, S. H.Abhyankar, S.Basu, Sandip2012-03-142012-03-142011Nuclear Medicine Communications, 2011. Vol. 32 (12): pp. 1201-1210http://hdl.handle.net/123456789/58705478 bytestext/htmlen[131I]metaiodobenzylguanidine (MIBG)neural crest tumorsneuroblastomaparagangliomapheochromocytomatherapy[131I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologiesArticle